# Assessing the efficacy and safety of rTMS, tDCS, and DBS in treating auditory hallucinations: a scoping review

**Authors:** Jiejun Wang

PMC · DOI: 10.3389/fnhum.2026.1769095 · Frontiers in Human Neuroscience · 2026-03-11

## TL;DR

This review compares the effectiveness and safety of three brain stimulation techniques for treating persistent auditory hallucinations.

## Contribution

The paper provides a comparative analysis of rTMS, tDCS, and DBS for auditory hallucinations through a scoping review.

## Key findings

- rTMS shows moderate efficacy with minimal side effects for treating auditory hallucinations.
- tDCS is a low-risk, cost-effective option but has limited evidence for long-term effectiveness.
- DBS demonstrates strong efficacy but involves higher risks due to its invasive nature.

## Abstract

Auditory hallucinations (AH)—the perception of sound in the absence of any external auditory stimulus—are among the most clinically significant and personally distressing symptoms encountered in psychiatry and neurology. Although AH is canonically associated with schizophrenia spectrum disorders, where it affects 60–80% of patients at some point in the illness course, it also emerges in major depressive disorder with psychotic features, bipolar disorder, post-traumatic stress disorder, borderline personality disorder, substance-induced psychoses, and a range of neurological conditions including epilepsy, Parkinson’s disease, Lewy-body dementia, and acquired brain injury. Patients with treatment-resistant AH (TR-AH) experience a substantial decline in their quality of life and face increased economic burden. The limitations of existing pharmaceutical treatments have spurred researchers to develop and assess neuroregulation techniques that can directly target abnormal neural circuits involved in the pathophysiology of AH. This review consolidates the current research findings of stimulation-based treatment methods for AH and aims to conduct an evidence-based evaluation of efficacy, safety, and practical feasibility of three neuromodulation methods: repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS). By making a comparison of these three methods, this review presents their respective risks and strengths and offers implications for future research direction.

## Linked entities

- **Diseases:** bipolar disorder (MONDO:0004985), post-traumatic stress disorder (MONDO:0005146), borderline personality disorder (MONDO:0001156), epilepsy (MONDO:0005027), Parkinson’s disease (MONDO:0005180), Lewy-body dementia (MONDO:0007488)

## Full-text entities

- **Diseases:** neurological conditions (MESH:D019636), Parkinson's disease (MESH:D010300), psychoses (MESH:D011618), depressive disorder (MESH:D003866), epilepsy (MESH:D004827), brain injury (MESH:D001930), AH (MESH:D006212), schizophrenia (MESH:D012559), borderline personality disorder (MESH:D001883), Lewy-body dementia (MESH:D020961), bipolar disorder (MESH:D001714), post-traumatic stress disorder (MESH:D013313)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13013423/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13013423/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC13013423/full.md

---
Source: https://tomesphere.com/paper/PMC13013423